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There are two species of ﬁlarial parasites with sheathless microﬁlariae known to
commonly cause parasitaemias in humans: Mansonella perstans and Mansonella ozzardi.
In most contemporary accounts of the distribution of these parasites, neither is usually
considered to occur anywhere in the Eastern Hemisphere. However, Sir Patrick Manson,
who ﬁrst described both parasite species, recorded the existence of sheathless sharp-tailed
Mansonella ozzardi-like parasites occurring in the blood of natives from New Guinea in
each and every version of his manual for tropical disease that he wrote before his death in
1922. Manson's reports were based on his own identiﬁcations and were made from at
least two independent blood sample collections that were taken from the island. Paciﬁc
region Mansonella perstans parasitaemias were also later (in 1923) reported to occur in
New Guinea and once before this (in 1905) in Fiji. Although Mansonella-parasitaemias
are generally regarded as benign, they are thought to be of public health importance
because they can affect the epidemiological monitoring of other ﬁlarial diseases. In this
article, we reviewed the historic literature concerning Paciﬁc-origin Mansonella-para-
sitaemias in an attempt to explain how, despite repeated reports of Paciﬁc-region Man-
sonella-parasitaemias, by as early as the 1970s, the WHO had arrived at the present-day
view that Wuchereria bancrofti is the only cause of ﬁlarial parasitaemias in Papua New
Guinea. We have also evaluated the evidence supporting the contemporary existence of
Paciﬁc-area parasitaemia-causing Mansonella parasites and assessed the relevance such
parasites could have for present-day lymphatic ﬁlariasis elimination efforts in the region.1. Present perspectives on the global distribution of
human Mansonella parasitism
Bain et al recently reviewed the genus of Mansonella placing
three species known to parasitize humans in the genus: Man-
sonella perstans (M. perstans), Mansonella ozzardi (M. ozzardi)
andMansonella streptocerca (M. streptocerca) [1]. Other species
of Mansonella parasites, which principally infect animals, are
also known to cause zoonosis in humans, however, such
events are rare and have not yet been recorded to cause
human parasitaemias, which would require an infecting female
parasite to develop to maturity, mate, and then begin releasing
microﬁlariae into an infected individual's blood [2,3].M. streptocerca is also not usually regarded as causing human
parasitaemias as M. streptocerca microﬁlariae, like those of
Onchocerca volvulus, are usually found only in the skin and
not in the blood [2]. Both M. perstans and M. ozzardi,
however, are thought to commonly cause blood parasitaemias.
M. perstans, for example, has been estimated to be infecting
around 114 million Africans and is also thought to occur in
South America [4–6]. M. ozzardi is thought to be widespread
throughout Latin America and the Caribbean but is not usually
recorded outside the New World [4–11]. Most contemporary
accounts of the distribution of Mansonella parasites exclude
the Paciﬁc and, in fact, all of the Eastern Hemisphere [4–11].
2. Historic accounts of Mansonella parasitaemias
from the Paciﬁc region
In 1897, Sir Patrick Manson reported that he had found ‘a
small sharp-tailed, sheathless ﬁlaria closely resembling, if notn access article under the CC BY-NC-ND license
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living on the ‘north-east coast’ of New Guinea (NG) [12]. Shortly
after this ﬁrst report, which most likely came from material
originating in what is present day Northern or Oro Provence
of present day Papua New Guinea (PNG), Manson went on to
describe further Mansonella parasites from blood slides sent to
him by Seligmann and taken from a native residing in what is
now the Kairuku-Hiri district of PNG. Manson reportedly
described these parasites as ‘identical in appearance to Filaria
demarquaii (F. demarquaii)’ [12,13]. Today, most contemporary
identiﬁcations of ﬁlarial worms are done using microﬁlariae and
‘Filaria Demarquayi’ and ‘F. demarquaii’ are both regarded as
synonyms of M. ozzardi [1,14,15]. Using the modern WHO's
‘Bench Aids for the Diagnosis of Filarial Infections’, thus, the
New Guinean parasitaemias that Manson reported as being
caused by ‘minute non-sheathed, sharp-tailed’ microﬁlariae
can be conﬁdently classiﬁed as M. ozzardi parasites—exactly as
Manson tentatively classiﬁed them more than 100 years ago [13–
16]. Lynch reported ﬁnding M. perstans (under the synonym
Filaria perstans) occurring in the blood of a native from the
Fijian Provence of ‘Lau’ and Cilento reported M. perstans
from the Dutch side of NG [17–19]. After Cilento's report,
Manson's Tropical Disease began recording the parasite as
probably occurring in NG and the parasite can be seen
recorded on the Dutch side of the island up to and including
the 18th edition of the book [20]. Sharp also described
M. perstans as occurring in NG writing that its presence in the
island was ‘recorded by Manson himself’ [21], which may
have been a reference to Manson-Bahr's reporting of the
parasite in Manson's Tropical Diseases. Given Manson's
unquestionable interest in M. perstans and the fact that
Lynch's report was published in the highly inﬂuential British
journal the Lancet, it would be surprising if Manson was
unaware of Lynch's report. Manson's son-in-law (Manson-
Bahr) who edited his ‘manual of diseases of warm climates’ was
certainly aware of Lynch's report as he cited the paper in which
the report was made [22]. The omission of Fijian M. perstans
from Manson's tropical disease manual and elsewhere cannot
therefore be viewed as a simple oversight on the part of the
ﬁlarial worm establishment and thus the possibility that there
were (presently unclear) well-grounded genuine scientiﬁc rea-
sons to doubt the legitimacy of Lynch's report can not be
reasonably ignored [5,16,23–31].
3. The disappearance of NG Mansonella
parasitaemias from the scientiﬁc literature
In contrast to Lynch's reports of Fijian M. perstans, Manson's
reports of M. ozzardi or a M. ozzardi-like parasite in NG were
widely accepted and extensively cited during his life-time
[12,16,21–25,32–38]. The reports appeared in the ﬁrst edition of
Manson's ‘manual of diseases in warm climates’ and in all
subsequent editions he published up to and including the last
he wrote before his death [16,22–25]. The disappearance from
the mainstream scientiﬁc literature of these NG Mansonella
parasites and the M. perstans that Cilento reported was a
gradual process that seems to have begun with the publication
of the 7th edition of Manson's Tropical Disease in which
Manson's son-in-law (Manson-Bahr) effectively declared PNG
free of M. ozzardi with the remark: ‘As far as it is known,
Filaria ozzardi (F. ozzardi) is conﬁned to the West Indies and
South America’ [26]. This revised distribution is notaccompanied by a retraction of Manson's original reports and
occurred at the same time that the book began formally
synonymizing Filaria demarquayi (F. demarquayi) and
F. demaraquaii with F. ozzardi (see Table 1)—all of which
are today regarded as synonyms of M. ozzardi [26]. Manson-
Bahr's remarks can be seen as a natural progression of the
revisions that Manson himself carried-out to the previous edi-
tions of this book. In the ﬁrst edition of this manual it appears
Manson is actually naming the PNG microﬁlariae M. ozzardi
(under the synonym F. demarquaii) (see Table 1). As early as
the second edition (published in 1900), however, signs of
Manson's reticence to name the PNG microﬁlariae as M. ozzardi
are evident as Manson introduces the caveat that (before PNG
M. ozzardi parasites can be classiﬁed as such) adult forms need
to be: ‘discovered and compared’ (to other ﬁlarial parasites) [16].
Manson's growing reticence is evident from the qualiﬁcation he
added to this caveat in the 5th and 6th editions of his book from
when he begins to write that adults need to be ‘discovered and
carefully compared’ [24,25]. By the 11th edition of the book
Manson-Bahr is referring to these very same PNG parasites as
belonging to a similar or related species and remarking that
M. ozzardi is difﬁcult to distinguish from the M. perstans, which
by this time he is acknowledging probably also occur in the
island. Manson's grandson's ﬁlarial parasite distribution map
also acknowledged the occurrence of M. perstans on the Dutch
side of NG, however, he made no mention of any parasitism-
causing Mansonella parasite occurring anywhere on the island
within the text of the book he edited [20]. In-line with the rest of
mainstream scientiﬁc literature and Hawking and Denham who
asserted in their 1970s WHO report that ‘Wuchereria bancrofti
(W. bancrofti) periodic type is the only human ﬁlarial worm
present’ in the PNG [39], Manson's Tropical Disease had wiped
all Mansonella parasites clean from the Eastern Hemisphere of
their maps by the 20th edition of their book [28].
4. A modern perspective on Manson's descriptions of
parasitaemia-causing ﬁlariae from PNG
There are presently no parasitaemia-causing microﬁlariae
matching Manson's description thought to occur in PNG, the
Paciﬁc region or in fact anywhere in the Eastern Hemisphere
[1,5,6]. Just like today, at the time of Manson's ﬁrst report of
M. ozzardi-like parasites, W. bancrofti was the only
parasitaemia-causing ﬁlaria thought to occur in PNG and then,
as now, these two parasites were regarded as easy to discrimi-
nate on the basis of microﬁlariae alone and thus the possibility
that Manson repeatedly misidentiﬁed W. bancrofti as
M. ozzardi-like parasites seems even less likely than the possi-
bility that M. ozzardi-like parasites are routinely being mis-
identiﬁed as W. bancrofti today. Owing to the difﬁculty in
obtaining adult specimens, since Manson's death very few (if
any) adult M. ozzardi have been recovered from humans and
contemporary accounts of their distribution are based almost
entirely on the identiﬁcation of microﬁlariae alone [1,5,6]. Since
the advent of molecular systematics, however, it has been
possible to look for ﬁlarial parasite diversity below the level
visible from microﬁlariae morphology (without obtaining adult
specimens) by comparing fast evolving DNA sequences like
the CO1 and certain rDNA sequences of the parasites [1,10,40–
46]. While this approach to the parasite identiﬁcation has not
been as widely used as it could or should have been, it has
been used and to date there is evidence for just two
Table 1
Manson's reporting on M. ozzardi-like parasites from Papua New Guinea.
Edition Year Section title and quote
1st 1898 FILARIA DEMARQUAII
In examining blood, sent me by Dr. Newsam, from natives of St. Vincent,
West Indies, I found this blood worm in several individuals …. I have
recently met with, apparently, the same parasite in the blood of natives of St.
Lucia, W.I. and of New Guinea. It is quite possible that the sharp-tailed ﬁlaria
(f. Ozzardi) of British Guiana is the same species.
2nd 1900 FlLARlA DEMARQUAII.
I have also found a minute, non-sheathed, sharp-tailed embryo ﬁlaria in the
blood of natives of New Guinea likewise closely resembling F. demarquaii.
Whether these various minute sharp-tailed, non-sheathed embryos belong to
one or to several species is impossible to decide until the parental forms have
been discovered and compared.
3rd 1903 FILARIA DEMARQUAII, Manson, 1895.
I have also found a minute, non-sheathed, sharp-tailed embryo ﬁlaria in the
blood of natives of New Guinea closely resembling F. demarquaii. Whether
these various minute sharp-tailed, non-sheathed embryos belong to one or to
several species is impossible to decide until the parental forms have been
discovered and compared.
4th 1907 FILARIA DEMARQUAII, Manson, 1895.
I have also found a minute, non-sheathed, sharp-tailed microﬁlaria in the
blood of natives of New Guinea closely resembling m.f. demarquaii. Whether
these various minute sharp-tailed, non-sheathed embryos belong to one or to
several species is impossible to decide until the adult forms have been
discovered and compared.
5th 1914 Under the section: Microﬁlaria demarquaii, Manson, 1895.
I have also found a minute, non-sheathed, sharp-tailed microﬁlaria, closely
resembling m.f. demarquaii, in the blood of natives of New Guinea. Whether
these various minute sharp-tailed, non-sheathed embryos belong to one or to
several species is impossible to decide until the adult forms have been
discovered and carefully compared.
6th 1917 Under the section: MICROFILARIA DEMARQUAII, Manson, 1895.
I have also found a minute, non-sheathed, sharp-tailed microﬁlaria, closely
resembling m.f. demarquaii, in the blood of natives of New Guinea. Whether
these various minute sharp-tailed, non-sheathed embryos belong to one or to
several species is impossible to decide until the adult forms have been
discovered and carefully compared.
7th 1921 Under the heading Filaria ozzardi, Manson, 1897. Synonyms:
F. demarquayi, F. juncea, Railliet.
‘It was ﬁrst thought that smaller embryos from the natives of St. Vincent
represented a different species, distinguished by Manson as F. demarquayi,
but it is now generally recognised that only one species exists. As far as it is
known, F. ozzardi is conﬁned to the West Indies and South America.’
The underlining used here on the word ‘careful’ introduced here is for stress and do not exist in the original quote.
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M. ozzardi and M. perstans—which are the same two sheathless
parasitaemia-causing ﬁlaria which Manson was aware of at the
time of his death [1,4–6,10,40–46]. Today, both M. perstans and
M. ozzardi parasitaemias are most often diagnosed using
almost the same criteria that Manson used, namely using the
morphology of the microﬁlariae and their absence of
periodicity in the blood [4–6,15]. Morphologically, Mansonella
genus microﬁlariae that cause parasitaemias can be
discriminated from the other known parasitaemia-causing
ﬁlarial parasite species and from each other by their size, their
absence of a sheath and their tail shape [1,4–6,15,45].
5. The absence of M. ozzardi-like parasites from
modern PNG ﬁlarial maps
As humanMansonella parasites are not known to be vectored
by mosquitoes, W. bancrofti transmission monitoring of wild-
caught mosquito vectors is unlikely to detect or be affected by
the existence of occult M. ozzardi-like ﬁlarial populations [2,4–6].Similarly as Mansonella parasitaemias are mostly or entirely
asymptomatic, and certainly have no clearly deﬁned symptoms
to diagnose them, clinicians are in no position to diagnose
infections without blood tests [2,4–6]. Blood examinations are
thus the only method that parasites might be expected to be
detected [2,4–6]. Over the last 15 years, ﬁlarial parasite
mapping in PNG has been done almost exclusively using
immunological assays that test blood samples for circulating
W. bancrofti antigens and most recently predominately with
ICT cards, which would not reveal the presence of an
unexpected M. ozzardi-like parasite [46–49].
Although, intuitively, light-microscopy-based malaria blood
surveys might be thought to detect ﬁlarial parasites if any were
present and such surveys have detected M. ozzardi in the past,
this type of survey cannot reasonably be expected to have found
Mansonella parasites in PNG [50]. This is because malaria
parasites are found using high-magniﬁcation objectives rather
than the low magniﬁcation objectives that are used to ﬁnd ﬁlarial
parasitaemias [51–53]. Sir Patrick Manson actually advocated the
need for schools of tropical medicine (before the London School
J. Lee Crainey et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(3): 205–210208of Hygiene and Tropical Medicine and the Liverpool School of
Tropical Medicine existed) using this counter-intuitive fact as an
example of the sort of thing that needs to be taught. In his
address on ‘the necessity for special education in tropical
medicine’ Manson is reported as saying: ‘ﬁlariae should be
sought with an inch objective otherwise they will be missed’ and
that although ‘in searching the blood for ﬁlaria—a large ﬁeld
is indispensable’ this ‘self-evident fact’ is one that ‘He (the
student of tropical medicine) seldom arrives at spontaneously’
[51–53]. Microscope based ﬁlarial surveys—which the WHO
presently recommends should use a 10× objective to ﬁnd
W. bancrofti—should, however, quite reasonably, have been
expected to also have found Manson's M. ozzardi-like
parasites if any had occurred in the tested blood samples
[51–53]. Trained microscopists should have no problem
discriminating between the much larger periodic sheathed
W. bancrofti and the unsheathed M. ozzardi-like parasites that
Manson reported even if they were not expecting to see them
[15,53].
In a 2013 review about lymphatic ﬁlariasis in PNG, 155
microscopy-based ﬁlarial surveys from PNG were reported to
have been conducted between 1980 and 2011, without any new
reports of Mansonella or Mansonella-like parasites causing
parasitaemias in the area [47]. Similarly, in two other detailed
reviews of microﬁlarial surveying covering the period from
Manson's ﬁrst report of M. ozzardi in 1897 up to Hawking and
Denham's 1971 WHO report declaring W. bancrofti as the only
ﬁlarial parasite to occur in PNG, only Seligmann (1901) and
Cilento (1923) have provided ﬁrst-hand accounts of Mansonella
parasites causing parasitaemias [12,13,18,39,54]. The primary source
data supporting the contemporary existence of Mansonella-
caused parasitaemias occurring in NG cannot be, therefore,
regarded as strong. Likewise, however, when this survey data is
assessed by geography, it can be seen that the localities that the
parasites were ﬁrst recorded in have not been rigorously
surveyed and thus that the evidence that the parasites have been
lost from NG is also not strong [39,47,54]. Between 1980 and
2011, there were no microﬁlarial surveys in the ‘Central’
Provence where Seligmann's report ﬁrst originated and there
seems to have been just one survey conducted in the Provence
(in 1936) after his report [47,55]. Although it is more difﬁcult to
be sure where exactly the M. ozzardi-like parasites that Manson
recorded as deriving from the ‘north-east coast’ of NG
originated, it is also likely that this locality has also not been
rigorously surveyed [12,39,47,54]. At the time of Manson's report
what is now known as the Northern or Oro province was the
most north-easterly part of what was then British NG and thus
this Provence is likely to be where the parasites he described came
from [12,39]. Oro Provence, which is more than 20000 km2 in size,
was surveyed at just one coastal locality (Oro Bay) between 1980
and 2011 and prior to this once at the inland town of Popondetta in
1966 [39,47,54].
Little is known of the epidemiology of M. ozzardi, however,
from what is known it is clear that M. ozzardi can be stably
maintained over long periods of time in very localized foci
[11,12,36,37,50,56–58]. In at least three of the Caribbean islands
where M. ozzardi has been recorded (St. Vincent, St Lucia
and Nevis), the parasites seem to have been stably maintained
with just a single village focus [12,36,37,49,55]. And in almost
all of the islands where the parasites' distribution has been
studied, it appears that their distribution is localized to just
one or two areas [11,12,36,37,50,57,58]. While most of theCaribbean islands have not been well-sampled since the
1940s, the evidence that the parasites can be maintained (even
with ongoing anti-ﬁlarial mass-drug distribution) has been
clearly shown in both Trinidad and Haiti [11,36,37,50,57,58]. In
Haiti, where most of the recent Caribbean surveying has
occurred it is apparent the parasites have been maintained in
the island for over 90 years [11,36,37,56,58]. If the known
M. ozzardi epidemiology in the Caribbean is taken as a guide
for what could be happening in NG, the possibility of occult
M. ozzardi or M. ozzardi-like parasitaemias continuing to
occur in localized foci of NG is difﬁcult to rule out.
6. The possible impact of occult M. ozzardi-like blood
parasitaemias in PNG on W. bancrofti
epidemiological monitoring and control
Accurate ﬁlarial parasite distribution maps are key to the
success of the Global Programme to Eliminate Lymphatic
Filariasis (GPELF) [47,48,59,60]. Historically, lymphatic ﬁlariasis
control efforts have made use of light-microscopy based
microﬁlariae surveys, circulating antigen and antibody detection
assays to plan control programs in PNG [47]. Since 2000,
however, most mapping data have derived from circulating
antigen assays and most predominately from diagnoses made
with the immunochromatographic card test (ICT), which have
been performed without the fear of other ﬁlarial parasite
species affecting their accuracy [47]. Although the speciﬁcity
of ICT cards has been tested against M. ozzardi parasites from
Bolivia and ICT-based mapping of W. bancrofti has been car-
ried out in co-endemic counties like Haiti, there are no gua-
rantees that W. bancrofti elimination efforts would be unaffected
by the existence of occult M. ozzardi or M. ozzardi-like para-
sitaemias in PNG or indeed the existence of such parasites in
Haiti or beyond [61–63]. Preliminary testing of the ICT cards
suggested that they did not cross-react with Loa loa and/or
M. perstans, however, recent ﬁeld studies in Africa have shown
that they can [64]. Other immunological assays for W. bancrofti
detection can and have been used for W. bancrofti diagnoses in
the Paciﬁc region, but none of the cross-reactivity testing of
these tests could be regarded as much more rigorous than the
ICT evaluations [65,66]. Cross-reactivity issues are also known to
affect the security of antibody detecting immunological assays.
For example, the ov16 antibody detection assay, which has been
used effectively for onchocerciasis control and proven especially
important for recrudescence monitoring throughout Africa and
in many parts of Latin America, cannot be used safely in the
Amazonia onchocerciasis focus because it can cross-react with
M. ozzardi-positive sera [67,68]. Similarly, alternative anti-
O. volvulus antibody detecting assays have also been shown to
cross-react with M. ozzardi-positive sera from some
geographic regions and not others [68].
Present plans for W. bancrofti elimination in PNG involve
focussing resources and control efforts on the endemic areas. As
Kairuku-Hiri district (where M. ozzardi were last recorded to
occur) is classiﬁed as non-endemic for W. bancrofti, it is un-
likely to be surveyed as part of the GPELF's existing plans [47].
Extrapolating from recent surveying efforts, it would seem,
moreover, that even if the site were to be surveyed for the
presence of W. bancrofti, it is unlikely that it would be
surveyed with the sort of PCR or light-microscopy microﬁ-
larial surveys that might be expected to uncover the existence of
M. ozzardi parasitaemias [47]. Because more than 1000 ICT card
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being detected, it is clear that M. ozzardi parasites have not
previously impacted on W. bancrofti monitoring in Kairuku-
Hiri district and so an argument could be made that the pres-
ence or absence of M. ozzardi or M. ozzardi-like parasites in this
area (or indeed all of PNG) is irrelevant for GPELF efforts [47].
Even if this perspective is adopted, however, surveying the
Kairuku-Hiri district for M. ozzardi or M. ozzardi-like para-
sites could still prove very useful to control efforts. This is
because uncovering a M. ozzardi or M. ozzardi-like focus could
provide a useful resource not only to conﬁrm the security of ICT
card testing in the area, but also as a useful resource for testing
the security of other diagnostic tools such as Bm14-based assays
which are likely to prove important for the recrudescence
monitoring of the GPELF [47,48,59,60,66].
Because M. ozzardi or M. ozzardi-like infections have not
been recorded from over 155 microscope surveys in the last 30
years, it is unlikely that they are presently common in PNG. It
is, thus, likewise unlikely that they have had a major impact on
W. bancrofti mapping efforts to date whether they still occur in
PNG or not. It is, however, important to note that if such par-
asites do exist and interfere with the accuracy of lymphatic
ﬁlariasis disease and disease-risk mapping efforts, their impor-
tance will only grow as the GPELF gets nearer its target and the
number of W. bancrofti parasites in the PNG diminishes
[47,48,59,60]. In light of this, whether surveys in Kairuku-Hiri
district ﬁnd the parasite or not, it may prove prudent for the
GPELF to shift away from its present focus on immunological-
based diagnosis of W. bancrofti blood infections in the PNG and
begin to introduce at least some W. bancrofti DNA-detection
based diagnostic techniques, with the capacity to detect more
than one type of ﬁlarial parasite [44,46,49]. Many PCR tests of
this nature have been developed and could be used for this
purpose [44,46,49]. Tang et al. reported one such test that is
presently being recommended for the detection of O. volvulus
DNA [44] and which has recently been shown to be highly
sensitive at detecting M. ozzardi blood samples [40,49]. This
test has also been shown to be capable of amplifying
W. bancrofti DNA and therefore could be, potentially, adapted
to reliably diagnose W. bancrofti infections and distinguish
them from any M. ozzardi or M. ozzardi-like blood
parasitaemias [40,44,49].
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